G01N 2440/32
Biotinylation
Official title: biotinylation
G01N2440/32 (Biotinylation) appears on 6 US grants and 15 published applications in this corpus.
Search patents in G01N- Granted patents
- 6
- Published applications
- 15
- Assignees
- 14
- Inventors
- 43
- Latest grant
- 5 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 3 |
| 2016 | 1 | 2 |
| 2017 | 2 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 2 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for determining long non-coding ribonucleic acid interaction proteins5 May 2026US 12,618,097 B2City University of Hong Kong
- Plasmonic biosensor24 Dec 2024US 12,174,182 B2Ecole Polytechnique Federale De Lausanne (Epfl)
- Anti-biotin antibody and application thereof13 Jun 2023US 11,673,969 B2Hangzhou Biolynx Technology Co., Ltd.
- Methods and reagents for improved selection of biological materials22 Aug 2017US 9,739,768 B2Russell Biotech, Inc.
- Proximity assay for in situ detection of targets30 May 2017US 9,663,814 B2Ventana Medical Systems, Inc.
- Profiling newly-synthesized glycoproteins as molecular signatures of injury in donor organs18 Jun 2026US 2026/0169002 A1Carnegie Mellon University
- Intracellular glycan proximity labeling methods and applications thereof2 Jan 2025US 2025/0003977 A1Wayne State University
- Anti-biotin antibody and application thereof10 Feb 2022US 2022/0041755 A1Hangzhou Biolynx Technology Co., Ltd.
- Method for Determining Long Non-Coding Ribonucleic Acid Interaction Proteins4 Nov 2021US 2021/0340592 A1City University of Hong Kong
- Plasmonic biosensor18 Feb 2021US 2021/0048435 A1Ecole Polytechnique Federale De Lausanne (Epfl)
Most cited
By later US patents